Comparative Clinical Trial of Amoxycillin and Chloramphenicol in the Treatment of Typhoid in Adults

1979 ◽  
Vol 7 (3) ◽  
pp. 247-252 ◽  
Author(s):  
C U Abengowe

A randomized clinical trial in sixty-two adult patients suffering from typhoid fever, proved by blood and marrow culture, showed that amoxycillin in a dosage schedule of 1 g 8-hourly orally for fourteen days was better than chloramphenicol with regard to clinical and temperature response and in respect of carriers and relapse rates. One patient developed a hypersensitivity reaction to amoxycillin which cleared on withdrawal of the drug. Success was achieved in 90% of cases. These findings lend very strong support to the value of amoxycillin as a superior alternative to chloramphenicol in the treatment of typhoid fever.

2009 ◽  
Vol 81 (2) ◽  
pp. 330-334 ◽  
Author(s):  
Tranquilino T. Fajardo ◽  
Robert H. Gelber ◽  
Rodolfo M. Abalos ◽  
Jasmin Burgos ◽  
Laarni Villahermosa ◽  
...  

2014 ◽  
Vol 19 (3) ◽  
pp. 215-221 ◽  
Author(s):  
Honorio Izquierdo Pérez ◽  
Jose Luis Alonso Perez ◽  
Alfonso Gil Martinez ◽  
Roy La Touche ◽  
Sergio Lerma-Lara ◽  
...  

2014 ◽  
Vol 30 (5) ◽  
pp. 487-492 ◽  
Author(s):  
WeiWei Zhang ◽  
Xi Chen ◽  
Ming-Wen Fan ◽  
Jan Mulder ◽  
Marie-Charlotte C.D.N.J.M. Huysmans ◽  
...  

2009 ◽  
Vol 181 (4) ◽  
pp. 561 ◽  
Author(s):  
Carlos A Bezerra ◽  
Eric Roger Wroclawsky ◽  
Alexandre O Rodrigues ◽  
Rodrigo Tristao ◽  
Milton Borrelli

2021 ◽  
Vol 10 (22) ◽  
pp. 5340
Author(s):  
Lourdes Montero-Cruces ◽  
Manuel Carnero-Alcázar ◽  
Fernando José Reguillo-Lacruz ◽  
Francisco Javier Cobiella-Carnicer ◽  
Daniel Pérez-Camargo ◽  
...  

Background: We aimed to compare 1 year the hemodynamic in-vivo performance of three biological aortic prostheses (Carpentier Perimount Magna EaseTM, Crown PRTTM, and TrifectaTM). Methods: The sample used in this study comes from the “BEST-VALVE” clinical trial, which is a phase IV single-blinded randomized clinical trial with the three above-mentioned prostheses. Results: 154 patients were included. Carpentier Perimount Magna EaseTM (n = 48, 31.2%), Crown PRTTM (n = 51, 32.1%) and TrifectaTM (n = 55, 35.7%). One year after the surgery, the mean aortic gradient and the peak aortic velocity was 17.5 (IQR 11.3–26) and 227.1 (IQR 202.0–268.8) for Carpentier Perimount Magna EaseTM, 21.4 (IQR 14.5–26.7) and 237.8 (IQR 195.9–261.9) for Crown PRTTM, and 13 (IQR 9.6–17.8) and 209.7 (IQR 176.5–241.4) for TrifectaTM, respectively. Pairwise comparisons demonstrated improved mean gradients and maximum velocity of TrifectaTM as compared to Crown PRTTM. Among patients with nominal prosthesis sizes ≤21, the mean and peak aortic gradient was higher for Crown PRTTM compared with TrifectaTM, and in patients with an aortic annulus measured with metric Hegar dilators less than or equal to 22 mm. Conclusions: One year after surgery, the three prostheses presented a different hemodynamic performance, being TrifectaTM superior to Crown PRTTM.


Sign in / Sign up

Export Citation Format

Share Document